219 related articles for article (PubMed ID: 1279309)
1. Therapy with and assessment of class III antiarrhythmic agents in different patient populations.
Podrid PJ
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S44-58. PubMed ID: 1279309
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
[TBL] [Abstract][Full Text] [Related]
3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
4. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
Borggrefe M; Haverkamp W; Shenasa M; Hindricks G; Breithardt G
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S32-40. PubMed ID: 1279307
[TBL] [Abstract][Full Text] [Related]
5. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the noninvasive approach.
Andresen D; Behrens S; Stern R; Brüggemann T; Schröder R
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S28-31. PubMed ID: 1279306
[TBL] [Abstract][Full Text] [Related]
6. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
8. [Anti-arrhythmic therapy and cardiac failure].
Cosnay P; Babuty D; Charniot JC; Fauchier L; Fauchier JP
Arch Mal Coeur Vaiss; 1995 Dec; 88 Spec No 5():35-41. PubMed ID: 8729298
[TBL] [Abstract][Full Text] [Related]
9. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Brachmann J
Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in the prevention and treatment of arrhythmia.
Auer J; Berent R; Eber B
Curr Opin Investig Drugs; 2002 Jul; 3(7):1037-44. PubMed ID: 12186264
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
[TBL] [Abstract][Full Text] [Related]
12. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia.
Celiker A; Koçak G; Lenk MK; Alehan D; Ozme S
Turk J Pediatr; 1997; 39(2):219-25. PubMed ID: 9223920
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and treatment of ventricular arrhythmias: an update.
McCollam PL; Parker RB
Clin Pharm; 1991 Mar; 10(3):195-205. PubMed ID: 2040126
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of amiodarone.
Nolan PE; Nappi J; Pollak PT
Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
[TBL] [Abstract][Full Text] [Related]
15. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
[TBL] [Abstract][Full Text] [Related]
16. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
McKenna WJ; Kleinebenne A
Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Follath F; Candinas R; Frielingsdorf J
Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
[TBL] [Abstract][Full Text] [Related]
18. Management of ventricular arrhythmias.
Aronow WS
Compr Ther; 1988 Aug; 14(8):25-30. PubMed ID: 3048863
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
Cairns JA
Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
[TBL] [Abstract][Full Text] [Related]
20. [Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs?].
Steinbeck G
Z Gesamte Inn Med; 1992 May; 47(5):195-201. PubMed ID: 1615729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
